RT Journal Article
SR Electronic
T1 Early evidence for the safety of certain COVID-19 vaccines using empirical Bayesian modeling from VAERS
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.06.10.21258589
DO 10.1101/2021.06.10.21258589
A1 Chris von Csefalvay
YR 2021
UL http://medrxiv.org/content/early/2021/06/13/2021.06.10.21258589.abstract
AB The advent of vaccines against SARS-CoV-2 ushered in an unprecedented global response to COVID-19, with the largest and most ambitious mass vaccination campaign in human history. The scale of this effort means that safety signals suggesting adverse effects may only be detectable using passive reporting. This paper examines reports to the CDC/FDA’s VAERS system in the first six months of 2021, using an empirical Bayesian model with a gamma Poisson shrinker to identify potential safety signals from COVID-19 vaccines currently on the U.S. market. Based on this preliminary data, it is concluded that the COVID-19 vaccine’s safety significantly exceeds that of previously marketed vaccines, and other than a known risk of thrombotic events, no safety signals of concern emerge.Competing Interest StatementCvC is a consultant to a company that may be affected by the research reported in this paper. The company had no influence upon the formulation, analysis or publication of this manuscript.Funding StatementResearch leading to this manuscript has been funded by Starschema, Inc. Starschema, Inc. had no influence upon the formulation, analysis or publication of this manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No IRB approval was sought because the research did not concern human subjects or identifiable patient data. All source data were publicly available from the CDC/FDA VAERS website.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data sources are publicly available from the CDC. The source code is available under https://github.com/chrisvoncsefalvay/vaers-covid. https://github.com/chrisvoncsefalvay/vaers-covid